Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.

The following faculty indicated no significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:

Sven Cnattingius
Joep Geraedts
Yvonne L. Giwercman
Jean Marc Kaufman
Petter Kristensen
Sheena E. M. Lewis
Jorn Olsen
Manuela Simoni
Jesper Smeenk
Marcello Spanò
Ulf Strömberg
Axel P. N. Themmen
Paolo Vineis

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:

Jan-Åke Gustafsson - Declared to receive grants and contracts from Karo Bio AB. Declared to receive honoraria or consultation fees from Karo Bio AB. Declared to be a member of Biolight AB advisory board. Declared to stakeholder in following companies (including such things as stock ownership) or options to buy, own, or have applied for patents related to a company’s product, receive royalties for previous activities, employment, consultation services etc.): Karo Bio AB, Biolight AB.

Rafael Oliva - Declared to receive Public Research Grant

Lone Schmidt - Declared to receive honoraria or consultation fees from Organon